Search results for

Gilead Sciences is donating its initial supply of the experimental treatment for COVID-19. The federal government is deciding where the scarce medicine goes, and there are questions about the choices.

NPR's Scott Simons asks Economist correspondent Nicolas Pelham about Syria's first lady, Asma al-Assad, and how she has profited during the decade-long conflict in her country.

During the pandemic, the U.S. couldn't import enough gloves. Recently, car makers ran out of semiconductors. So the White House wants to find ways to make more critical items in the United States.

The then-president asked a Georgia law enforcement official to find evidence of fraud with absentee-by-mail ballots. He told her: "When the right answer comes out, you'll be praised."

"China's law does not really encourage people to defend themselves, because that would be encouraging them to rise up and resist [authority]," a Chinese lawyer noted.

After a two-year legal saga, Safehouse says it will open next week, allowing users to administer illegal drugs under supervision. Federal officials say they will try to stop the site from opening.

Crops like radishes, jicama and cilantro will soon be grown close to the Strip, so restaurants will have immediate access to fresh ingredients, instead of having to wait for trucks from California.

The Dow Jones industrial average passed another milestone today. Here's a little explainer as to why stocks have done so well in recent years — and why it doesn't affect the wallets of most Americans.

Russell Begaye, president of the Navajo Nation, speaks about the successful effort of five Southwestern Indian tribes to convince President Obama to create Bears Ears National Monument in Utah.

U.S. veterans reflect on their time in Afghanistan as they watch the Taliban take power, uncertain of the fate of the people they know from their time at war.